$COPR
Idaho Copper Corp Stock $copr

$copr Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000149315223021184 Filed on June 14, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q2
Revenue		$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$401.2K	$4.153M	$30.30K
YoY Change	1223.96%	40102.23%	130.77%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$401.2K	$4.153M	$30.30K
YoY Change	1224.17%	40102.23%	130.7%
Operating Profit	-$401.2K		-$30.30K
YoY Change	1224.17%		130.7%
Interest Expense	$107.2K	-$341.0K	$102.4K
YoY Change	4.64%
% of Operating Profit
Other Income/Expense, Net	-$173.8K	-$6.100K
YoY Change
Pretax Income	-$575.0K	-$4.299M	-$30.30K
YoY Change	1798.0%	41521.2%	130.7%
Income Tax
% Of Pretax Income
Net Earnings	-$575.0K	-$4.299M	-$30.30K
YoY Change	1798.01%	41521.2%	130.7%
Net Earnings / Revenue
Basic Earnings Per Share	$0.00
Diluted Earnings Per Share	$0.00	-$0.18
COMMON SHARES
Basic Shares Outstanding	208.8M shares	202.3M shares	20.05M shares
Diluted Shares Outstanding	17.96M shares		20.05M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$116.7K	$431.4K
YoY Change
Cash & Equivalents	$116.7K	$431.4K
Short-Term Investments
Other Short-Term Assets	$23.68K		$1.134M
YoY Change	-97.91%
Inventory
Prepaid Expenses	$23.68K
Receivables
Other Receivables
Total Short-Term Assets	$140.4K	$431.4K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$100.0K	$100.0K	$0.00
YoY Change
Total Long-Term Assets	$100.0K	$100.0K	$0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$140.4K	$431.4K
Total Long-Term Assets	$100.0K	$100.0K	$0.00
Total Assets	$240.4K	$531.4K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$283.4K	$354.8K
YoY Change
Accrued Expenses	$165.6K	$92.15K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$449.0K	$446.9K	$143.7K
YoY Change	212.47%	294.14%	75.61%
LONG-TERM LIABILITIES
Long-Term Debt	$3.422M	$3.353M	$0.00
YoY Change
Other Long-Term Liabilities	$1.424M	$1.352M
YoY Change
Total Long-Term Liabilities	$4.846M	$4.705M	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$449.0K	$446.9K	$143.7K
Total Long-Term Liabilities	$4.846M	$4.705M	$0.00
Total Liabilities	$5.295M	$5.152M	$143.7K
YoY Change	3585.44%	4443.57%	75.6%
SHAREHOLDERS EQUITY
Retained Earnings	-$28.46M	-$27.89M	-$7.397M
YoY Change	284.82%
Common Stock	$209.3K	$208.5K	$20.05K
YoY Change	943.87%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$5.055M	-$4.621M	-$143.7K
YoY Change
Total Liabilities & Shareholders Equity	$240.4K	$531.4K
YoY Change

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q2
OPERATING ACTIVITIES
Net Income	-$575.0K	-$4.299M	-$30.30K
YoY Change	1798.01%	41521.2%	130.7%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$314.7K	-$147.6K	$0.00
YoY Change			-100.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities			$0.00
YoY Change
Cash From Investing Activities			$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		361.0K	0.000
YoY Change			-100.0%
NET CHANGE
Cash From Operating Activities	-$314.7K	-147.6K	0.000
Cash From Investing Activities			0.000
Cash From Financing Activities		361.0K	0.000
Net Change In Cash	-$314.7K	213.4K	0.000
YoY Change
FREE CASH FLOW
Cash From Operating Activities	-$314.7K	-$147.6K	$0.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q2	dei	Document Period End Date DocumentPeriodEndDate	2023-04-30
CY2023Q2	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q2	dei	Entity Registrant Name EntityRegistrantName	IDAHO COPPER CORPORATION
CY2023Q2	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023Q2	dei	Entity File Number EntityFileNumber	333-108715
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2022Q2	GTVI	Amortization Of Debt Instrument Convertible Beneficial Conversion Feature AmortizationOfDebtInstrumentConvertibleBeneficialConversionFeature		usd
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2022Q2	us-gaap	Adjustment For Amortization AdjustmentForAmortization		usd
CY2023Q2	us-gaap	Recapitalization Costs RecapitalizationCosts		usd
CY2022Q2	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense		usd
CY2022Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities		usd
CY2022Q2	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities		usd
CY2023Q2	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022Q2	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023Q2	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2022Q2	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2023Q2	GTVI	Bond Liabilities Maturities In Year Three BondLiabilitiesMaturitiesInYearThree		usd
CY2023Q2	GTVI	Bond Liabilities Maturities In Year Four BondLiabilitiesMaturitiesInYearFour		usd
CY2023Q2	GTVI	Bond Liabilities Maturities Thereafter BondLiabilitiesMaturitiesThereafter		usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards		usd
CY2023Q2	GTVI	Deferred Tax Assets Timing Differences DeferredTaxAssetsTimingDifferences		usd
CY2022Q2	GTVI	Deferred Tax Assets Timing Differences DeferredTaxAssetsTimingDifferences		usd
CY2022Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross		usd
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance		usd
CY2023Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance		usd
CY2023Q2	dei	Document Type DocumentType	10-Q
CY2023Q2	dei	Entity Central Index Key EntityCentralIndexKey	0001263364
CY2023Q2	dei	Amendment Flag AmendmentFlag	false
CY2023Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--01-31
CY2023Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q2	us-gaap	Other Liability Current Related And Nonrelated Party Status Extensible Enumeration OtherLiabilityCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q1	us-gaap	Other Liability Current Related And Nonrelated Party Status Extensible Enumeration OtherLiabilityCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-0221494
CY2023Q2	dei	Entity Address Address Line1 EntityAddressAddressLine1	800 W. Main Street
CY2023Q2	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1460
CY2023Q2	dei	Entity Address City Or Town EntityAddressCityOrTown	Boise
CY2023Q2	dei	Entity Address State Or Province EntityAddressStateOrProvince	ID
CY2023Q2	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	83702
CY2023Q2	dei	City Area Code CityAreaCode	(208)
CY2023Q2	dei	Local Phone Number LocalPhoneNumber	274-9220
CY2023Q2	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q2	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q2	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q2	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	209337451	shares
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	116721	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	431374	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	23675	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	140396	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	431374	usd
CY2023Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	100000	usd
CY2023Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	100000	usd
CY2023Q2	us-gaap	Assets Assets	240396	usd
CY2023Q1	us-gaap	Assets Assets	531374	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	283361	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	354763	usd
CY2023Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	130333	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	83333	usd
CY2023Q2	us-gaap	Interest Payable Current InterestPayableCurrent	35268	usd
CY2023Q1	us-gaap	Interest Payable Current InterestPayableCurrent	8817	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	448962	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	446913	usd
CY2023Q2	us-gaap	Long Term Transition Bond LongTermTransitionBond	3135000	usd
CY2023Q1	us-gaap	Long Term Transition Bond LongTermTransitionBond	3135000	usd
CY2023Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	286995	usd
CY2023Q1	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	218429	usd
CY2023Q2	GTVI	Interest Payable Non Current InterestPayableNonCurrent	1424278	usd
CY2023Q1	GTVI	Interest Payable Non Current InterestPayableNonCurrent	1351609	usd
CY2023Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	4846273	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	4705038	usd
CY2023Q2	us-gaap	Liabilities Liabilities	5295235	usd
CY2023Q1	us-gaap	Liabilities Liabilities	5151951	usd
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	209337451	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	209337451	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	208457823	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	208457823	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	209337	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	208458	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	23199083	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	23059223	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-28463259	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-27888258	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-5054839	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-4620577	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	240396	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	531374	usd
CY2023Q2	us-gaap	Professional Fees ProfessionalFees	129145	usd
CY2022Q2	us-gaap	Professional Fees ProfessionalFees	94491	usd
CY2023Q2	GTVI	Payroll And Related Expenses PayrollAndRelatedExpenses	107000	usd
CY2022Q2	GTVI	Payroll And Related Expenses PayrollAndRelatedExpenses	14948	usd
CY2023Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	10500	usd
CY2022Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	10500	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	140741	usd
CY2023Q2	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	13770	usd
CY2022Q2	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1252	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	401156	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	121191	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-401156	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-121191	usd
CY2023Q2	GTVI	Amortization Of Debt Instrument Convertible Beneficial Conversion Feature AmortizationOfDebtInstrumentConvertibleBeneficialConversionFeature	66679	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	107166	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	102411	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-173845	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-102411	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-575001	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-223602	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	208754327	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20054000	shares
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-8294773	usd
CY2022Q2	GTVI	Stock Issued During Period Value Of Recapitalization StockIssuedDuringPeriodValueOfRecapitalization	4519207	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-223602	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-3999168	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-4620577	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-4620577	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	140739	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-575001	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-5054839	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-5054839	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-575001	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-223602	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	140741	usd
CY2023Q2	us-gaap	Adjustment For Amortization AdjustmentForAmortization	66679	usd
CY2022Q2	us-gaap	Recapitalization Costs RecapitalizationCosts	161176	usd
CY2023Q2	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	23675	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-69517	usd
CY2023Q2	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	47000	usd
CY2023Q2	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-99120	usd
CY2022Q2	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-101611	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-314653	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	39185	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-314653	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	39185	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	431374	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	217948	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	116721	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	257133	usd
CY2023Q2	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_802_eus-gaap--NatureOfOperations_zfJeeBwT4rnh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span id="xdx_829_ztnP75MviCok">NATURE OF OPERATIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The financial statements include the financial statements of Idaho Copper Corporation (formerly known as Joway Health Industries Group Inc.) (referred to herein as “Idaho Copper”). Idaho Copper is hereinafter referred to as the “Company,” “we” and “us.”</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 3, 2022, the Company consummated the transactions contemplated by the Stock Purchase Agreement dated as of January 31, 2022 (the “Purchase Agreement”), by and among the Company, Crystal Globe Limited, a company incorporated under the laws of British Virgin Islands (the “Seller”), and JHP Holdings, Inc., a Nevada corporation (the “Buyer”), pursuant to which the Buyer purchased <span id="xdx_905_eus-gaap--StockRepurchasedAndRetiredDuringPeriodShares_c20220201__20220203__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_zIFw2nSMW0Q1" title="Buyer purchased common stock shares">16,644,820</span> shares of common stock of the Company from the Seller.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 23, 2023, the Company entered into and consummated the transactions contemplated by a share exchange agreement (the “Share Exchange Agreement”) by and among the Company, International CuMo Mining Corporation, an Idaho corporation (“ICUMO”), and all of the shareholders of ICUMO (collectively, the “ICUMO Shareholders”). Pursuant to the terms of the Share Exchange Agreement (the “RTO”), the ICUMO Shareholders transferred all the issued and outstanding shares of common stock of ICUMO to the Company in exchange for <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230122__20230123__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember_zbJM920ffF5g" title="Number of shares issued">182,240,000</span> shares of the Company’s common stock, par value $<span id="xdx_90C_eus-gaap--EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased_c20230122__20230123__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember_znEEdHG1gIDc">0.001</span> per share. As a result of this share exchange (the “Exchange”), ICUMO became a wholly owned subsidiary of the Company. See Note 7.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company continues to be a “smaller reporting company,” as defined under the Exchange Act of 1934, as amended (the “Exchange Act”) following the Exchange, however, as a result of the Exchange, the Company has ceased to be a “shell company” (as such term is defined in Rule 12b-2 under the Exchange Act). </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ICUMO Background</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ICUMO is an exploration and development company with mineral right interests in the United States of America. ICUMO was originally incorporated under the laws of Nevada in 2005, as Mosquito Mining Corp. In 2013, the Company was moved to Idaho and the name changed to Idaho CuMo Mining Corporation. In early January 2023 the name was changed to International CuMo Mining Corporation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nature of Operations</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is in the process of exploring its mineral rights interests in the United States and at the date of these financial statements, has not yet determined whether any of its mineral properties contain economically recoverable mineral reserves. Accordingly, the carrying amount of mineral right interests represents cumulative expenditures incurred to date and does not necessarily reflect present or future values. The recovery of these costs is dependent upon the discovery of economically recoverable mineral reserves and the ability of ICMC to obtain the necessary financing to complete their exploration and development and to resolve any environmental, regulatory, or other constraints. Uncertainty also exists with respect to the recoverability of the carrying value of certain mineral rights interests. The ability of the Company to realize its investment in resource properties is contingent upon the resolution of the uncertainties and confirmation of the Company’s title to the mineral properties.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Share Price SharePrice	0.125
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Expiration Date ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate	2027-12-31
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	116721	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-575001	usd
CY2023Q2	GTVI	Working Capital WorkingCapital	308565	usd
CY2023Q2	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_848_eus-gaap--UseOfEstimates_z3MWBVifYrl6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_zFP5nUMgfQhd">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17960000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q1	GTVI	Unproven Mineral Right Interests UnprovenMineralRightInterests	0	usd
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	66993	usd
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	24254000	shares
CY2023Q2	us-gaap	Long Term Transition Bond LongTermTransitionBond	3135000	usd
CY2023Q2	us-gaap	Long Term Transition Bond LongTermTransitionBond	3135000	usd
CY2023Q2	GTVI	Bond Liabilities Maturities In Next Twelve Months BondLiabilitiesMaturitiesInNextTwelveMonths	1510000	usd
CY2023Q2	GTVI	Bond Liabilities Maturities In Year Two BondLiabilitiesMaturitiesInYearTwo	536000	usd
CY2023Q2	GTVI	Bond Liabilities Maturities In Year Five BondLiabilitiesMaturitiesInYearFive	1089000	usd
CY2023Q2	us-gaap	Long Term Transition Bond LongTermTransitionBond	3135000	usd
CY2023Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	510754	usd
CY2022Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	0	usd
CY2023Q2	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023Q2	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.05	pure
CY2023Q2	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-91195	usd
CY2022Q2	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-46956	usd
CY2023Q2	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-21713	usd
CY2022Q2	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-11180	usd
CY2023Q2	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	112908	usd
CY2022Q2	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	58137	usd
CY2023Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	510754	usd
CY2023Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	510754	usd
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	510754	usd
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	510754	usd

Files In Submission

Name	View Source	Status
0001493152-23-021184-index-headers.html	Edgar Link	pending
0001493152-23-021184-index.html	Edgar Link	pending
0001493152-23-021184.txt	Edgar Link	pending
0001493152-23-021184-xbrl.zip	Edgar Link	pending
ex21-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
ex4-1.htm	Edgar Link	pending
ex99-1.htm	Edgar Link	pending
ex99-1_001.jpg	Edgar Link	pending
ex99-1_002.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
form10-q_002.jpg	Edgar Link	pending
gtvi-20230430.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
gtvi-20230430_cal.xml	Edgar Link	unprocessable
gtvi-20230430_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
gtvi-20230430_lab.xml	Edgar Link	unprocessable
gtvi-20230430_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$COPR
Idaho Copper Corp Stock $copr

2023 Q2 Form 10-Q Financial Statement

#000149315223021184 Filed on June 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$COPR Idaho Copper Corp Stock $copr

2023 Q2 Form 10-Q Financial Statement

#000149315223021184 Filed on June 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$COPR
Idaho Copper Corp Stock $copr